FRANCHI MATTEO

Ruolo: 
Ricercatore a tempo determinato
Settore scientifico disciplinare: 
STATISTICA MEDICA (MED/01)
Telefono: 
0264485859
Stanza: 
U07, Piano: P02, Stanza: 2059
Via Bicocca degli Arcimboldi, 8 - 20126 MILANO

Pubblicazioni

  • Bonifazi, M., Sverzellati, N., Negri, E., Pomponio, G., Seletti, V., Bonini, M., et al. (2020). Increased prevalence of small airways dysfunction in patients with systemic sclerosis as determined by impulse oscillometry. RHEUMATOLOGY, 59(3), 641-649. Dettaglio
  • Rea, F., Ieva, F., Pastorino, U., Apolone, G., Barni, S., Merlino, L., et al. (2020). Number of lung resections performed and long-term mortality rates of patients after lung cancer surgery: evidence from an Italian investigation. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. Dettaglio
  • Franchi, M., Garau, D., Kirchmayer, U., Di Martino, M., Romero, M., Carlo, I., et al. (2020). Effectiveness and costs associated to adding cetuximab or bevacizumab to chemotherapy as initial treatment in metastatic colorectal cancer: Results from the observational fabio project. CANCERS, 12(4), 839. Dettaglio
  • Trifirò, G., Gini, R., Barone-Adesi, F., Beghi, E., Cantarutti, A., Capuano, A., et al. (2019). The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?. DRUG SAFETY, 42(3), 347-363. Dettaglio
  • Franchi, M., Barni, S., Tagliabue, G., Ricci, P., Mazzucco, W., Tumino, R., et al. (2019). Effectiveness of First-Line Bevacizumab in Metastatic Colorectal Cancer: The Observational Cohort Study GRETA. THE ONCOLOGIST, 24(3), 358-365. Dettaglio